ImmunityBio, Inc.: Neoplasm Metastasis trials
The registry lists 18 Neoplasm Metastasis studies with ImmunityBio, Inc. as lead sponsor. 0 are open to participants now and 13 have results posted.
Phase 1 13Phase 2 9Phase 3 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing CancerTerminatedNCT03127098Phase 1/2Results posted
- QUILT-3.028: Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid TumorsCompletedNCT03027128Phase 1Results posted
- Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue SarcomaCompletedNCT02235701Phase 1/2Results posted
- Phase 3 Study to Treat Patients With Soft Tissue SarcomasCompletedNCT02049905Phase 3Results posted
- A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid TumorsCompletedNCT01946789Phase 1Results posted
- QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT01670994Phase 1/2Results posted
- Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue SarcomaCompletedNCT01514188Phase 2Results posted
- A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial CancerCompletedNCT01326871Phase 1/2Results posted
- QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the PancreasCompletedNCT01231347Phase 3Results posted
- QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic MelanomaTerminatedNCT01029873Phase 1/2Results posted
- QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid TumorsTerminatedNCT00819169Phase 1/2Results posted
- QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast CancerCompletedNCT00626106Phase 2Results posted
- Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic MalignanciesCompletedNCT00496860Phase 1Results posted
- QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT04898543Phase 1
- QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid CancersCompletedNCT04050709Phase 1
- QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-PaclitaxelCompletedNCT02559674Phase 1
- A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsCompletedNCT01325558Phase 1
- QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal CarcinomaCompletedNCT00813605Phase 2